© 2021 MJH Life Sciences and Gene Therapy Live. All rights reserved.
© 2021 MJH Life Sciences™ and Gene Therapy Live. All rights reserved.
September 02, 2021
With numerous targets in CNS diseases and a unique partnership with gene therapy experts at UT Southwestern, Taysha is hoping to fill significant unmet needs.
September 01, 2021
The early-phase data readout follows news that the FDA recently approved its IND for its CAR-T candidate in multiple myeloma.
August 31, 2021
The first US-based patient has been dosed in Lysogene’s clinical trial of LYS-GM101, following 2 other competing trials.
August 27, 2021
The 4-day virtual conference will feature plenary presentations, workshops, and bootcamps led by cell therapy industry leaders with expertise in discovery, development, manufacturing, and more.